These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 2608299

  • 1. Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury.
    Lloyd LK, Richards JS.
    Paraplegia; 1989 Dec; 27(6):457-64. PubMed ID: 2608299
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Intracavernous pharmacotherapy for organic impotence in the elderly].
    Richter S, Shalev M, Nissenkorn I.
    Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intracavernous papaverine for impotence in spinal cord injured patients.
    Kapoor VK, Chahal AS, Jyoti SP, Mundkur YJ, Kotwal SV, Mehta VK.
    Paraplegia; 1993 Oct; 31(10):675-7. PubMed ID: 8259331
    [Abstract] [Full Text] [Related]

  • 10. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
    Sidi AA, Cameron JS, Duffy LM, Lange PH.
    J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S, Iwai Y, Yasumoto R, Matsuda J, Kawano M, Omachi T, Kono T, Yamamoto S, Sakakura T, Minami H.
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [Abstract] [Full Text] [Related]

  • 17. The use of vasoactive agents in the treatment of erectile impotence.
    Fried FA.
    N C Med J; 1990 Jun; 51(6):295-6. PubMed ID: 2366889
    [No Abstract] [Full Text] [Related]

  • 18. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM, Stevenson RW, Szasz G.
    J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
    JAMA; 1990 Aug 08; 264(6):752-4. PubMed ID: 2374280
    [No Abstract] [Full Text] [Related]

  • 20. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W, de la Fuente RB, Lycklama à Nijeholt AA, Vermeij P, Zwartendijk J.
    Int J Impot Res; 1996 Mar 08; 8(1):5-7. PubMed ID: 8735187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.